E-LIB Suche - Ergebnisse für: van Beurden-Tan, Chrissy

1

Cost-Effectiveness of Blinatumomab in Pediatric Patients wi..:

Caillon, Megane ; Brethon, Benoit ; van Beurden-Tan, Chrissy...
PharmacoEconomics - Open. 7 (2023) 4 - p. 639-653 , 2023

Link: https://doi.org/10.1007/..

2

Multinomial network meta-analysis using response rates: rel..:

van Beurden-Tan, Chrissy H. Y. ; Sonneveld, Pieter ; Groot, Carin A. Uyl-de
BMC Cancer. 22 (2022) 1 - p. , 2022

Link: https://doi.org/10.1186/..

3

Systematic Literature Review and Network Meta-Analysis of T..:

van Beurden-Tan, Chrissy H.Y. ; Franken, Margreet ; Blommestein, Hedwig..
Clinical Lymphoma Myeloma and Leukemia. 17 (2017) 1 - p. e144 , 2017

Link: https://doi.org/10.1016/..

4

Cost-Effectiveness of Blinatumomab in Pediatric Patients wi..:

Caillon, Megane ; Brethon, Benoit ; van Beurden-Tan, Chrissy...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333169/. , 2023

Link: http://www.ncbi.nlm.nih...

5

Multinomial network meta-analysis using response rates: rel..:

van Beurden-Tan, Chrissy H. Y ; Sonneveld, Pieter ; Groot, Carin A. Uyl-de
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9150316/. , 2022

Link: http://www.ncbi.nlm.nih...

6

Efficacy of first-line treatments for multiple myeloma pati..:

Blommestein, Hedwig M ; van Beurden-Tan, Chrissy H.Y ; Franken, Margreet G...
Blommestein , H M , van Beurden-Tan , C H Y , Franken , M G , Uyl-de Groot , C A , Sonneveld , P & Zweegman , S 2019 , ' Efficacy of first-line treatments for multiple myeloma patients not eligible for stem cell transplantation - A Network Meta-analysis ' , Haematologica , vol. 104 , no. 5 , pp. 1026-1035 . https://doi.org/10.3324/haematol.2018.206912. , 2019

Link: https://research.vumc.nl..

7

Efficacy of first-line treatments for multiple myeloma pati..:

Blommestein, H.M. (Hedwig) ; Beurden-Tan, C.H.Y. (Chrissy) van ; Franken, M.G. (Margreet)...
http://repub.eur.nl/pub/115152. , 2019

Link: http://repub.eur.nl/pub/..

8

Multinomial network meta-analysis using response rates: rel..:

Chrissy H. Y. van Beurden-Tan ; Pieter Sonneveld ; Carin A. Uyl-de Groot
https://doi.org/10.1186/s12885-022-09571-8. , 2022

Link: https://doi.org/10.1186/..

9

CO141 Assessing the Impact of Additional Follow-up Data on ..:

Chandler, T. ; Orsini, I. ; Van Beurden-Tan, C....
Value in Health. 26 (2023) 12 - p. S40 , 2023

Link: https://doi.org/10.1016/..

10

MO1 - COMBINING INTERNALLY VALID TRIAL EVIDENCE WITH GENERA..:

Blommestein, H. ; van Beurden-Tan, C. ; de Groot, S....
Value in Health. 21 (2018) - p. S10-S11 , 2018

Link: https://doi.org/10.1016/..

11

Cost-Effectiveness of Induction Treatment with Bortezomib A..:

van Beurden-Tan, C. ; Rosiñol, L. ; Diels, J....
Value in Health. 16 (2013) 7 - p. A409-A410 , 2013

Link: https://doi.org/10.1016/..